Basic HIV Vaccine Discovery Research (R01)
The summary for the Basic HIV Vaccine Discovery Research (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Basic HIV Vaccine Discovery Research (R01): Purpose. The aim of this Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is to stimulate the discovery of an effective prophylactic HIV-1 vaccine by soliciting Research Project Grant (R01) applications for hypothesis-driven basic research in HIV/AIDS, and general virology and immunology focused on that aim. The emphasis is on discovery, including the identification of new concepts and approaches that will inform the design of an optimal prophylactic HIV-1 vaccine, or the implementation of applicable concepts and/or approaches that have been employed successfully in the development of vaccines for other infections. Mechanism of Support. This FOA will utilize the NIH Research Project R01 grant mechanism. This FOA will utilize the NIH Research Project R01 grant mechanism, and runs in parallel with FOAs of similar scope, including PA-06-519 Phased Innovation Awards (PIA) in AIDS Vaccine Research and PAR-06-285 HIVRAD that solicit applications under the R21/R33 and P01 mechanisms, respectively. Funds Available and Anticipated Number of Awards. NIAID intends to commit approximately $10M in total costs in FY 2010 to fund 15-25 applications submitted in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
|Federal Grant Title:||Basic HIV Vaccine Discovery Research (R01)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-AI-09-024|
|Type of Funding:||Grant|
|CFDA Descriptions:||Allergy, Immunology and Transplantation Research|
|Current Application Deadline:||Nov 09, 2009|
|Original Application Deadline:||Nov 09, 2009|
|Posted Date:||May 19, 2009|
|Creation Date:||May 19, 2009|
|Archive Date:||Dec 10, 2009|
|Total Program Funding:||$10,000,000|
|Maximum Federal Grant Award:||$350,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
- Similar Government Grants
- • Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinica...
- • Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clini...
- • Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical T...
- • NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
- • Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 C...
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...